At EPA 2026, Stratence Partners will lead two executive sessions in the Pricing and AI tracks and host business-focused Poster Sessions on Commercial Transformation, AI Powered. Meet us at Booth 300A.

Ahead of EPA 2026, Stratence Partners is hosting a closed-door VIP Dinner for selected VP and C-level executives in Pricing, Market Access, Commercial and Finance governance.

EPA 2026: From Attendance to Impact The World Evidence, Pricing & Access Congress remains Europe’s most relevant gathering for senior leaders in pricing, market access, HEOR, and commercial strategy. But attendance alone does not create value. Impact comes from addressing structural weaknesses that silently erode EBIT year after year. As a global firm specialized in Commercial Transformation, AI Powered, Stratence Partners returns to EPA 2026 with two focused executive sessio

Stratence Partners will deliver two focused sessions at EPA 2026 addressing Gross-to-Net best practices and AI-driven commercial transformation. Join us March 3rd in Amsterdam.

Pharma transformations fail when operating models don’t evolve. Learn how Stratence Partners helps organizations embed change through governance, processes, and capability building.

Stratence Partners will be at the entrance of EPA 2026 — in Stand 300A. Come meet our global team and schedule a one-on-one with the right VP.

Stratence Partners will be at the entrance of EPA 2026 — in Stand 300A. Come meet our global team and schedule a one-on-one with the right VP.

Pharma generates data everywhere, but few companies turn it into actionable intelligence. Discover how Stratence Partners helps transform information into measurable strategic advantage.

Pharma strategy must evolve to stay ahead of innovation, regulation, and pricing challenges. Discover how Stratence Partners helps global pharma companies align vision, Market Access, and execution for measurable results.